News
A call for applications for the European Group on Ethics in Science and New Technologies (EGE) was launched by the European Commission. The EGE is an independent advisory body which was founded in 1991 and reports to the President of the European Commission and the College of Commissioners and acts under the direct responsibility of the European Commissioner for Innovation, Research, Culture, Education and Youth. Recent advice was provided on the following topics: the protection of fundamental rights in the COVID-19 pandemic, genome editing and artificial intelligence. The expert group will consist of up to 15 members. Members are appointed for a term of maximum 3 years which can be renewed a maximum of two times.
Applications should include a cover letter, curriculum vitae and standard declaration of interest and will have to be submitted via this website. The deadline for applications is 22 March 2021 (12:00 noon CET). Questions related to the application process can be addressed to EC-ETHICS-GROUP@ec.europa.eu.
All information related to the call can be found in this European Commission news article
myOverview
Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.
Only for stakeholders located in Flanders
On 5 November 2026, the European Commission published a correction for Horizon Europe topic HORIZON-CL6-2027-02-FARM2FORK-05. Under the section ‘Topic description - Scope’, the sentence on collaboration with projects funded under other topics in the work programme has been updated. The original text referred to...
Read moreAre you planning to submit a proposal under the EDF-EDIP-USI-2026-LS-IRA-MAB call? (EDF Call for proposals for industrial reinforcement actions under the Ukraine Support Instrument)The European Commission has published a revised version of the call document, taking into account the possibility that additional funding may become available under...
Read moreThe new Digital Europe calls are expected to open in January 2027. Now is the time to look for your potential partners and form consortia.
Read moreThe 2027 work programme opens funding opportunities worth over €1.8 billion for strategic technologies and scaling up companies. The EIC work programme 2027 details the funding in six main schemes: EIC Pathfinder EIC Transition Advanced Innovation Challenges EIC Accelerator The EIC Strategic Technologies for Europe Platform (STEP) Scale Up EIC...
Read moreTestimonial
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
